248 related articles for article (PubMed ID: 33673279)
21. Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.
Chubb D; Broderick P; Dobbins SE; Frampton M; Kinnersley B; Penegar S; Price A; Ma YP; Sherborne AL; Palles C; Timofeeva MN; Bishop DT; Dunlop MG; Tomlinson I; Houlston RS
Nat Commun; 2016 Jun; 7():11883. PubMed ID: 27329137
[TBL] [Abstract][Full Text] [Related]
22. Rare germline variants in known melanoma susceptibility genes in familial melanoma.
Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR
Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293
[TBL] [Abstract][Full Text] [Related]
23. New genes emerging for colorectal cancer predisposition.
Esteban-Jurado C; Garre P; Vila M; Lozano JJ; Pristoupilova A; Beltrán S; Abulí A; Muñoz J; Balaguer F; Ocaña T; Castells A; Piqué JM; Carracedo A; Ruiz-Ponte C; Bessa X; Andreu M; Bujanda L; Caldés T; Castellví-Bel S
World J Gastroenterol; 2014 Feb; 20(8):1961-71. PubMed ID: 24587672
[TBL] [Abstract][Full Text] [Related]
24. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
[TBL] [Abstract][Full Text] [Related]
25. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
26. Functional Common and Rare
Bao R; Ng A; Sasaki M; Esai Selvan M; Katti A; Lee H; Huang L; Skol AD; Lavarino C; Salvador H; Klein RJ; Gümüş ZH; Mora J; Onel K
Cancer Prev Res (Phila); 2021 Apr; 14(4):441-454. PubMed ID: 33419763
[TBL] [Abstract][Full Text] [Related]
27. Exome sequencing identifies potential novel candidate genes in patients with unexplained colorectal adenomatous polyposis.
Spier I; Kerick M; Drichel D; Horpaopan S; Altmüller J; Laner A; Holzapfel S; Peters S; Adam R; Zhao B; Becker T; Lifton RP; Holinski-Feder E; Perner S; Thiele H; Nöthen MM; Hoffmann P; Timmermann B; Schweiger MR; Aretz S
Fam Cancer; 2016 Apr; 15(2):281-8. PubMed ID: 26780541
[TBL] [Abstract][Full Text] [Related]
28. Somatic mutations and germline sequence variants in patients with familial colorectal cancer.
Gylfe AE; Sirkiä J; Ahlsten M; Järvinen H; Mecklin JP; Karhu A; Aaltonen LA
Int J Cancer; 2010 Dec; 127(12):2974-80. PubMed ID: 21351276
[TBL] [Abstract][Full Text] [Related]
29. Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei.
Lung MS; Mitchell CA; Doyle MA; Lynch AC; Gorringe KL; Bowtell DDL; ; Campbell IG; Trainer AH
BMC Cancer; 2020 May; 20(1):369. PubMed ID: 32357859
[TBL] [Abstract][Full Text] [Related]
30. Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis.
Adam R; Spier I; Zhao B; Kloth M; Marquez J; Hinrichsen I; Kirfel J; Tafazzoli A; Horpaopan S; Uhlhaas S; Stienen D; Friedrichs N; Altmüller J; Laner A; Holzapfel S; Peters S; Kayser K; Thiele H; Holinski-Feder E; Marra G; Kristiansen G; Nöthen MM; Büttner R; Möslein G; Betz RC; Brieger A; Lifton RP; Aretz S
Am J Hum Genet; 2016 Aug; 99(2):337-51. PubMed ID: 27476653
[TBL] [Abstract][Full Text] [Related]
31. A de novo germline mutation of APC for inheritable colon cancer in a Chinese family using multigene next generation sequencing.
Zhang Y; Lu G; Hu Q; Wang X; Li C; Mao Y; Cui M
Biochem Biophys Res Commun; 2014 May; 447(3):503-7. PubMed ID: 24735542
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel variants in colorectal cancer families by high-throughput exome sequencing.
DeRycke MS; Gunawardena SR; Middha S; Asmann YW; Schaid DJ; McDonnell SK; Riska SM; Eckloff BW; Cunningham JM; Fridley BL; Serie DJ; Bamlet WR; Cicek MS; Jenkins MA; Duggan DJ; Buchanan D; Clendenning M; Haile RW; Woods MO; Gallinger SN; Casey G; Potter JD; Newcomb PA; Le Marchand L; Lindor NM; Thibodeau SN; Goode EL
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1239-51. PubMed ID: 23637064
[TBL] [Abstract][Full Text] [Related]
33. A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome.
Jiang Y; Sun Y; Hu J; Yu N; Liu H; Fan J; Ning X; Li Y; Liu B; Sun Y; Zhang J; Qiu X; Fu S; Zhou C; Xu H
BMC Cancer; 2019 Jun; 19(1):613. PubMed ID: 31226964
[TBL] [Abstract][Full Text] [Related]
34. Founder Mutations for Early Onset Melanoma as Revealed by Whole Exome Sequencing Suggests That This is Not Associated with the Increasing Incidence of Melanoma in Poland.
Dębniak T; Scott RJ; Lea RA; Górski B; Masojć B; Cybulski C; Kram A; Maleszka R; Gromowski T; Paszkowska-Szczur K; Kashyap A; Lener MR; Malińska K; Rogoża E; Murawa D; Rudnicka H; Deptuła J; Lubiński J
Cancer Res Treat; 2019 Jan; 51(1):337-344. PubMed ID: 29764119
[TBL] [Abstract][Full Text] [Related]
35. Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch Syndrome.
Hansen MF; Johansen J; Sylvander AE; Bjørnevoll I; Talseth-Palmer BA; Lavik LAS; Xavier A; Engebretsen LF; Scott RJ; Drabløs F; Sjursen W
Clin Genet; 2017 Oct; 92(4):405-414. PubMed ID: 28195393
[TBL] [Abstract][Full Text] [Related]
36. Germline Genetic Features of Young Individuals With Colorectal Cancer.
Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
[TBL] [Abstract][Full Text] [Related]
37. The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery.
Hahn MM; de Voer RM; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP; van Kessel AG
Cell Oncol (Dordr); 2016 Dec; 39(6):491-510. PubMed ID: 27279102
[TBL] [Abstract][Full Text] [Related]
38. Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancer.
Smith CG; Naven M; Harris R; Colley J; West H; Li N; Liu Y; Adams R; Maughan TS; Nichols L; Kaplan R; Wagner MJ; McLeod HL; Cheadle JP
Hum Mutat; 2013 Jul; 34(7):1026-34. PubMed ID: 23585368
[TBL] [Abstract][Full Text] [Related]
39. Identification of Rare Variants Predisposing to Thyroid Cancer.
Wang Y; Liyanarachchi S; Miller KE; Nieminen TT; Comiskey DF; Li W; Brock P; Symer DE; Akagi K; DeLap KE; He H; Koboldt DC; de la Chapelle A
Thyroid; 2019 Jul; 29(7):946-955. PubMed ID: 30957677
[No Abstract] [Full Text] [Related]
40. Systematic search for rare variants in Finnish early-onset colorectal cancer patients.
Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Järvinen H; Mecklin JP; Böhm J; Kilpivaara O; Pitkänen E; Palin K; Vahteristo P; Tuupanen S; Aaltonen LA
Cancer Genet; 2015; 208(1-2):35-40. PubMed ID: 25749350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
